TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 37 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $89,938 | +36.6% | 47,586 | +7.7% | 0.00% | – |
| Q4 2022 | $65,846 | -20.7% | 44,192 | -11.3% | 0.00% | – |
| Q3 2022 | $83,000 | -9.8% | 49,818 | +8.8% | 0.00% | – |
| Q2 2022 | $92,000 | -84.5% | 45,800 | -79.6% | 0.00% | – |
| Q1 2022 | $592,000 | -8.1% | 224,943 | -3.2% | 0.00% | – |
| Q4 2021 | $644,000 | +30.9% | 232,475 | +82.5% | 0.00% | – |
| Q3 2021 | $492,000 | +147.2% | 127,366 | +315.4% | 0.00% | – |
| Q2 2021 | $199,000 | -37.0% | 30,662 | -20.0% | 0.00% | – |
| Q1 2021 | $316,000 | +119.4% | 38,332 | +211.3% | 0.00% | – |
| Q4 2020 | $144,000 | +193.9% | 12,315 | -50.3% | 0.00% | – |
| Q2 2020 | $49,000 | +28.9% | 24,769 | +54.3% | 0.00% | – |
| Q4 2019 | $38,000 | – | 16,049 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $9,004,920 | 2.70% |
| Ikarian Capital, LLC | 2,765,530 | $5,226,851 | 1.19% |
| JOHNSON & JOHNSON | 84,003 | $158,766 | 0.05% |
| X-Square Capital, LLC | 17,743 | $34 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $489,215 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $859,791 | 0.01% |
| HoyleCohen, LLC | 13,000 | $24,570 | 0.00% |
| MGO ONE SEVEN LLC | 11,780 | $22,264 | 0.00% |
| Bank of New York Mellon Corp | 66,606 | $125,885 | 0.00% |
| Citadel Advisors | 24,700 | $46,683 | 0.00% |